Quarterly report pursuant to Section 13 or 15(d)

Note 10 - Share-based Compensation - Schedule of Options (Details)

v3.25.0.1
Note 10 - Share-based Compensation - Schedule of Options (Details)
 3 Months Ended
Dec. 31, 2024
USD ($)
$ / shares
shares
Outstanding, balance (in shares) | shares 18,462,428
Outstanding, exercise price (in dollars per share) | $ / shares $ 4.59
Granted (in shares) | shares 240,000
Granted, exercise price (in dollars per share) | $ / shares $ 0.77
Exercised (in shares) | shares 0
Exercised, exercise price (in dollars per share) | $ / shares $ 0
Forfeited and expired (in shares) | shares (554,867)
Forfeited and expired, exercise price (in dollars per share) | $ / shares $ 5.52
Outstanding, balance (in shares) | shares 18,147,561
Outstanding, exercise price (in dollars per share) | $ / shares $ 4.51
Outstanding, remaining contractual term (Year) 5 years 9 months 3 days
Outstanding, intrinsic value | $ $ 16,944
Exercisable (in shares) | shares 14,133,583
Exercisable, exercise price (in dollars per share) | $ / shares $ 4.76
Exercisable, remaining contractual term (Year) 4 years 11 months 1 day
Exercisable, intrinsic value | $ $ 0